Global Custom Assays Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Custom Assays Market Research Report 2024
Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes.
According to MRAResearch’s new survey, global Custom Assays market is projected to reach US$ 51450 million in 2033, increasing from US$ 36690 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Custom Assays market research.
Key companies engaged in the Custom Assays industry include Thermo Fisher Scientific, Bio-Rad, Roche Life Science, Fluidigm, Promega, Merck, GE Healthcare Lifescience, Cisbio and Biosensorix, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Custom Assays were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Custom Assays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Custom Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience
Segment by Type
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Custom Assays report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Custom Assays market is projected to reach US$ 51450 million in 2033, increasing from US$ 36690 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Custom Assays market research.
Key companies engaged in the Custom Assays industry include Thermo Fisher Scientific, Bio-Rad, Roche Life Science, Fluidigm, Promega, Merck, GE Healthcare Lifescience, Cisbio and Biosensorix, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Custom Assays were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Custom Assays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Custom Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience
Segment by Type
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others
Segment by Application
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Custom Assays report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source